Background and Purpose: Structural network analysis of diffusion imaging is increasingly used to
Introduction
The neurological impact of pathology is increasingly understood in terms of dysfunctional groups of interconnected regions, as per the framework of network theory. 1, 2 In glioma, widespread functional connections are altered, correlating with patient functioning. [3] [4] [5] [6] [7] [8] Network 'hubs', i.e. extensively connected regions, seem most vulnerable to this dysfunction. 4, [6] [7] [8] [9] Network theory also offers mathematical insight on how particularly increased hub-related connectivity relates to later large-scale network failure, 10, 11 and may therefore explain clinical decline that cannot be explained by currently used radiological features across several neurological diseases. 2, [12] [13] [14] In newly diagnosed glioma, hub-related functional connectivity in the hemisphere contralateral to the tumor is increased, 7 possibly reflecting network failure in response to local dysfunction as an initially compensatory but long-term detrimental relaying of load. 10 Structural connectivity throughout macroscopically tumor-free brain regions also experimentally associates with molecular subtype 15 and prognosis, 16 indicating that connectivity measures may inform our understanding of performance status and survival beyond the currently known molecular determinants.
We retrospectively investigated structural connectivity in newly diagnosed glioma patients, assessing altered structural connectivity, its associations with functioning and survival, and differences between molecular subtypes. We hypothesized that higher hub-non-hub-related connectivity would reflect lower performance status, shorter survival, and unfavorable molecular subtype, while maintained hub-connectivity would associate with better performance, longer survival, and favorable molecular subtype.
Materials and Methods

Participants
Newly diagnosed glioma patients that underwent diffusion imaging (dMRI) and T1-3D
imaging at the time of diagnosis between January 2006 and December 2013 were retrospectively included. Inclusion criteria were histologically confirmed glioma, dMRI available before diagnostic surgery and/or treatment, and T1-3D imaging at the same time point. Exclusion criteria were previous craniotomy, previous chemo/radiotherapy, bilateral tumor invasion or significant midline shift, and neurological or psychiatric comorbidity, although presence of seizures was allowed given the frequency of seizures in glioma patients. The Institutional Review Board approved the retrospective analysis of patient data used, and we adhered to HIPAA regulations dealing with these data. As a healthy control group, we used a cohort that was collected in a different hospital. 
MRI
The diffusion sequence used in patients consisted of 21 diffusion-encoding gradient directions, and a b-value of 1000 (TR=5400ms, 1.38x1.38mm 2 in-plane resolution). Healthy controls underwent imaging with 30 gradient directions at a b-value of 900 (TR=13000ms, 2x2mm 2 in-plane resolution). Figure 1 schematically depicts our analysis pipeline. Imaging processing steps were performed using FSL 5.0.9 (http://www.fmrib.ox.ac.uk/fsl). Non-brain tissue was removed using the Brain Extraction Tool, 23 tissue segmentation was performed using FAST. 24 The Automated Structural Labeling (AAL) atlas was used to define 78 cortical regions in each subject's native space after registration with FLIRT. 25 Tumor masks were created manually using contrast enhancing T1-weighted and FLAIR images. Tumor volume was calculated using this mask.
Diffusion images were visually inspected for artifacts and/or excessive motion, then corrected for motion and eddy current distortion using FMRIB's Diffusion Toolbox, 26 which was also used to fit the voxelwise diffusion tensor. Diffusion images were co-registered to individual T1s with epi_reg.
Voxels forming the grey/white matter rim were seeds in subsequent probabilistic tractography (ProbtrackX2, 5000 streamlines per voxel). Tract likelihood was determined by averaging the number of streamlines reaching each atlas region from each other region across all voxels (excluding all tumor mask voxels), then normalizing this value for seed region size.
Hub-related connectivity
Connectivity analyses were performed using Matlab R2012a (Mathworks, Natick, MA, US). Binary connectivity matrices were created by thresholding the number of normalized streamlines reaching their target in >5% of runs. In controls, the median density (i.e. number of connections) of the patients was used to threshold the weighted average of the left and right hemisphere control matrices, in order to keep the total number of connections comparable between patients and controls.
Hub locations were in accordance with the literature, encompassing eight regions falling within the default mode 27, 28 and frontoparietal networks. 29, 30 This ensured that spatial shifts in hub regions in patients would not drive our findings concerning alterations in connectivity of the wellknown hubs of the human brain. Finally, we calculated the total number of connections per hemisphere, as well as the number of connections between hubs, hubs and non-hubs, and non-hubs for each subject.
Statistical analysis
Matlab and SPSS 22.0 (IBM Corp, Armonk, NY, US) were used with an alpha level of 0.05. Patientcontrol characteristics were tested using Chi-square tests (sex) and Student's t-test for independent samples (age).
Connectivity was non-normally distributed according to Kolmogorov-Smirnov tests.
Differences in the number of connections between patients and controls were explored using Wilcoxon signed rank tests, corrected for eight comparisons using Bonferroni correction (significance level P < 0.006). Associations between significantly altered connectivity and KPS were tested using MannWhitney U-tests, while associations between hub connectivity and survival were investigated using log-rank tests, both with Bonferroni correction.
Differences in hub-related connectivity depending on molecular subtype were explored using
Mann-Whitney U-tests. An uncorrected P < 0.05 was considered statistically significant for these exploratory analyses.
Results
Subject characteristics
In total, 293 newly diagnosed, preoperative glioma patients were screened for inclusion. One patient was excluded because of neurological comorbidities, 69 and 82 due to absence of dMRI or 3D-T1
imaging, respectively, 38 due to scanning artifacts, while another 39 patients underwent dMRI with different scanning sequences, leaving 65 patients for final analysis. We found no significant differences in age or sex between patients and controls ( Table 2) .
Patients had more contralateral hub-related connections than controls
There were no significant differences between patients and healthy controls in ipsilateral or contralateral connection density, nor did patients have an altered number of non-hub connections in either hemisphere (Table 2 and 
Higher hub-hub connectivity related to favorable molecular subtype
Without correction for multiple comparisons, non-GBM IDH mut patients had a significantly higher number of contralateral hub connections than IDH wt patients (see table 3 ). There were no differences in hub-non-hub connections according to molecular subtypes.
Discussion
We report higher hub-related structural connectivity in glioma patients in the hemisphere contralateral to the tumor, as compared to healthy controls. The total number of connections and number of (hubrelated) connections in the macroscopically invaded hemisphere did not differ between groups, nor could altered hub-related connectivity be attributed to tumor grade, volume, overlap with hub regions, or AED and/or corticosteroid use. Furthermore, higher contralateral hub-non-hub connectivity related to poorer performance status, while higher contralateral hub-hub connectivity related to a favorable molecular subtype in terms of IDH mutation status.
Increased hub-related connectivity may speculatively support the hypothesis that these patients are in the first phase of cascadic network failure, as has been proposed and experimentally investigated in other neurological diseases. 2, 12 Connectivity between non-hubs and hubs is thought to increase due to local dysfunction and subsequent relaying of connectivity towards the network backbone, 10, 11, 13 as confirmed by increased hub-related functional connectivity in newly diagnosed glioma patients. 7 Conversely, maintained (or in this case: higher) hub-hub connectivity may indicate that the entire connectome has not collapsed yet, which would indicate the chronic phase of hub overload.
Previous studies have reported on (long-distance) reductions in connectivity, without exploring possible increases in structural connectivity. 31, 32 However, white matter integrity may increase at the scale of days in the setting of external brain stimulation. 33 Our current results suggest that glioma is also able to induce higher white matter integrity at a distance from the tumor, be it a pathological sign of disease stage, compensatory (as suggested by the hub-hub association with favorable molecular subtype), or both. Of course, we cannot fully exclude the possibility that patients already had higher numbers of structural connections than controls before developing glioma, or that differing scanning protocols induces group differences between patients and controls. However, the within-patient associations found for both hub-non-hub connectivity (with unfavorable performance status) and hub-hub connectivity (with favorable mutation status) suggest that these factors do not confound the clinical implications of our findings. Futhermore, our results regarding lowered hub-hub connectivity in IDH wt patients corroborate a previous study of global structural network efficiency, 15 as Kesler and colleagues show that IDH wt patients have reduced global efficiency as compared to IDH mut patients.
In the context of cascadic network failure, most previous work was performed using functional connectivity. 7, 12 Multimodal investigation of connectivity may prove essential to fully understanding the course of disease and performance status as a result of particular molecular subtypes of glioma. Also, it remains unclear how neuronal biology leads to circuit activity at the scale of thousands of cells, or how this circuitry precisely relates to macroscopic patterns of connectivity measured with MRI. We here chose to approach glioma from the complex network perspective in a top-down manner: if we assume that the macroscopic structural brain network adheres to mechanisms defined in other complex networks, and these mechanisms relate to relevant patient characteristics such as performance status and survival, future studies may use these findings to further uncover the underlying mechanisms from the bottom-up.
Another limitation of this study is its retrospective nature, limiting the availability of clinical information. Replication of our results in a prospective cohort of patients and controls is necessary.
Our cross-sectional study also does not elucidate the timeframe in which connectivity alterations may have developed in glioma patients. Secondly, the boundaries of gliomas are challenging to define, so we cannot fully exclude carry-over tumor effects on contralateral diffusion measurements.
Furthermore, we used mostly functionally determined hub locations, instead of defining hubs based on (individual) structural data. Although the correlation between structural and functional connectivity has been shown particularly strong for the hub connections, 34 future work may address the question whether the structural hubs we defined here are exactly identical to functional hubs on an individual level. Finally, optimal tractography methodology is currently debated upon, particularly due to false positives. 35 However, we were primarily interested in hub connections, which are likely less influenced by weighted/proportional thresholding than non-hub connections, due to their overall higher strength and replicability. Furthermore, the use of a rather coarse atlas and limited number of diffusion gradients does imply greater clinical potential across a range of scanners.
Conclusions
Our results reveal higher hub-related connectivity in glioma patients as compared to healthy controls, which may carry clinical information in terms of performance status and molecular subtype. We speculate that the co-occurrence of higher hub-related connectivity and lower performance status may indicate that these patients are in the first phase of hub overload. Conversely, maintained and/or higher hub-related connectivity may offer resilience in patients with favorable molecular subtypes. Our results offer a first step towards new avenues for the adequate understanding and possible future prognostic use of network failure in glioma patients. (14) Males ( Note. * = P < 0.05 after correction for multiple comparisons, Mdn = median, ipsi = ipsilateral to the tumor, contra = contralateral to the tumor, IQR = interquartile range. 
